Business
CSL (ASX:CSL) share price wobbles on COVID vaccine news – The Motley Fool Australia
The CSL Limited (ASX: CSL) share price is on watch after the UK found “possible links” between the AstraZeneca vaccine and blood clots.
The CSL Limited (ASX: CSL) share price is a little wobbly this morning after negative vaccine news overnight from the United Kingdom.
The pharmaceutical giant, which produces and supplies the AstraZeneca PLC (LSE: AZ)COVID-19 vaccine in Australia, is trading close to its opening price after news that the UK medical regulator has found a “possible link” between the vaccine and blood clotting in younger adults. The regulator noted that blood clotting was considered a rare side-effect of the vaccine.
…
-
Noosa News23 hours agoMan charged with domestic violence offence after Gold Coast crash that killed 3yo boy
-
Noosa News22 hours agoSix to Try: Cafes in Brisbane Shaking Things Up
-
Noosa News21 hours agoQueensland government makes three-year 8 per cent pay rise offer to state’s school teachers
-
General22 hours agoLittle Zak’s Academy closes centre in Doonside after childcare workers charged